Latham Steers As Biotech Firm's $56M IPO Tops Range
Lyra Therapeutics Inc. started trading Friday after raising $56 million in an initial public offering steered by Latham & Watkins LLP that saw the life sciences company price at the top...To view the full article, register now.
Already a subscriber? Click here to view full article